1.Lymphoplasmacytic non-Hodgkin lymphoma/Waldenstrom's macroglobulinemia with CD5+, CD23+, and CD10-.
Guido D'ANGELO ; Anna Maria HOTZ ; Marta MONTI
Blood Research 2013;48(4):300-303
No abstract available.
Waldenstrom Macroglobulinemia*
2.Waldenstrom's macroglobulinemia presenting with lytic bone lesions: a rare presentation.
Mukta PUJANI ; Shivani KUSHWAHA ; Neha SETHI ; Anu BENIWAL ; Shailaja SHUKLA
Blood Research 2013;48(3):230-233
No abstract available.
Waldenstrom Macroglobulinemia
3.Waldenström macroglobulinemia presenting with neurological symptoms after chemotherapy.
Muhammad Shariq SHAIKH ; Bushra MOIZ
Blood Research 2016;51(1):6-6
No abstract available.
Drug Therapy*
;
Waldenstrom Macroglobulinemia*
4.Waldenstrom's macroglobulinemia associated with eosinophilia.
Eunkyoung YOU ; Kyung Sam CHO ; Tae Sung PARK
Blood Research 2013;48(1):8-8
No abstract available.
Eosinophilia
;
Waldenstrom Macroglobulinemia
5.Waldenstrom's macroglobulinemia associated with eosinophilia.
Eunkyoung YOU ; Kyung Sam CHO ; Tae Sung PARK
Blood Research 2013;48(1):8-8
No abstract available.
Eosinophilia
;
Waldenstrom Macroglobulinemia
6.A case of Waldenstrom's macroglobulinemia, without bone marrow involvement.
Jung Woong LEE ; Seung Soo PARK ; Kung Whan KIM ; Jong Hyun KIM ; Young Sung JAE ; Ok Ji BACK
Korean Journal of Hematology 1992;27(2):421-425
No abstract available.
Bone Marrow*
;
Waldenstrom Macroglobulinemia*
7.A prospective clinical trial of TCD-induced regimen for symptomatic Waldenström macroglobulinemia.
Yan Shan HUANG ; Wen Jie XIONG ; Ying YU ; Yu Ting YAN ; Ting Yu WANG ; Rui LYU ; Wei LIU ; Gang AN ; Yao Zhong ZHAO ; De Hui ZOU ; Lu Gui QIU ; Shu Hua YI
Chinese Journal of Hematology 2023;44(8):680-683
8.Diffuse Large B-cell Lymphoma in Waldenstrom Macroglobulinemia.
Ji Hae LEE ; Joo Hee LEE ; Chae Young WON ; Ji Hyun LEE ; Kyung Moon KIM ; Si Yong KIM
Korean Journal of Dermatology 2014;52(1):70-72
No abstract available.
B-Lymphocytes*
;
Lymphoma, B-Cell*
;
Waldenstrom Macroglobulinemia*
10.What is the most appropriate regimen for untreated Waldenström macroglobulinemia?
Naohiro SEKIGUCHI ; Airi HAMANO ; Tomoko KITAGAWA ; Kenichi ITO ; Kazuhiko HIRANO ; Kazuaki YAMADA
Blood Research 2019;54(2):153-156
No abstract available.
Cost-Benefit Analysis
;
Rituximab
;
Waldenstrom Macroglobulinemia
Result Analysis
Print
Save
E-mail